Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
36.304 (110/303) |
1.17E-45 |
MAP3K7 C-terminal-like protein (MAP3K7CL)
|
47.552 (68/143) |
2.82E-37 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
31.203 (83/266) |
3.41E-31 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
35.688 (96/269) |
2.78E-30 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
29.861 (86/288) |
4.29E-27 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
27.626 (71/257) |
1.19E-26 |
Serine/threonine-protein kinase 24 (STK24)
|
|
33.202 (84/253) |
1.29E-26 |
Serine/threonine-protein kinase 26 (STK26)
|
|
32.411 (82/253) |
3.76E-26 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
30.224 (81/268) |
3.90E-25 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
29.568 (89/301) |
4.33E-25 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
31.621 (80/253) |
4.34E-25 |
Ste-20-related kinase (STK39)
|
|
32.130 (89/277) |
4.59E-25 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
28.058 (78/278) |
6.16E-25 |
Oxidative stress responsive 1 (OXSR1)
|
|
30.769 (88/286) |
6.31E-25 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
29.885 (78/261) |
1.11E-24 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
34.632 (80/231) |
1.26E-24 |
PAK-2 protein kinase (PAK2)
|
|
32.422 (83/256) |
1.54E-24 |
PAK-4 protein kinase (PAK4)
|
|
29.134 (74/254) |
2.00E-24 |
Aurora kinase A (AURKA)
|
|
29.104 (78/268) |
2.29E-24 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
31.203 (83/266) |
2.59E-24 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
28.627 (73/255) |
3.15E-24 |
Serine/threonine-protein kinase 25 (STK25)
|
|
29.452 (86/292) |
4.97E-24 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
30.075 (80/266) |
5.08E-24 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
35.377 (75/212) |
5.82E-24 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
27.778 (70/252) |
6.94E-24 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
33.778 (76/225) |
7.12E-24 |
NIMA-related kinase 1 (NEK1)
|
|
25.397 (64/252) |
8.14E-24 |
PAK-1 protein kinase (PAK1)
|
|
31.641 (81/256) |
1.03E-23 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
32.685 (84/257) |
1.30E-23 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
30.435 (84/276) |
1.81E-23 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
29.286 (82/280) |
2.09E-23 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
30.888 (80/259) |
2.94E-23 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
28.912 (85/294) |
4.30E-23 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
30.169 (89/295) |
4.83E-23 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
31.250 (80/256) |
5.29E-23 |
Aurora kinase C (AURKC)
|
|
30.292 (83/274) |
5.31E-23 |
Myosin light chain kinase 2 (MYLK2)
|
|
30.500 (61/200) |
6.90E-23 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
32.296 (83/257) |
7.86E-23 |
Fused homolog (STK36)
|
|
31.698 (84/265) |
1.16E-22 |
MEK kinase kinase 3 (MAP4K3)
|
|
29.562 (81/274) |
1.19E-22 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
33.491 (71/212) |
3.32E-22 |
TAO kinase 1 (TAOK1)
|
|
31.228 (89/285) |
3.66E-22 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
34.300 (71/207) |
9.73E-22 |
Serine/threonine-protein kinase 10 (STK10)
|
|
31.321 (83/265) |
1.10E-21 |
Doublecortin-like kinase 3 (DCLK3)
|
|
28.464 (76/267) |
1.29E-21 |
MST-1 protein kinase (STK4)
|
|
29.344 (76/259) |
1.41E-21 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
28.016 (72/257) |
1.59E-21 |
ERK activator kinase 2 (MEK2)
|
|
34.694 (68/196) |
2.55E-21 |
Serine/threonine-protein kinase 3 (STK3)
|
|
29.730 (77/259) |
3.13E-21 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
27.381 (69/252) |
3.66E-21 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
30.980 (79/255) |
3.68E-21 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
34.667 (78/225) |
4.52E-21 |
Doublecortin-like kinase 1 (DCLK1)
|
|
31.527 (64/203) |
1.25E-20 |
NIMA-related kinase 6 (NEK6)
|
|
25.651 (69/269) |
1.26E-20 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
26.246 (79/301) |
1.40E-20 |
NIMA-related kinase 2 (NEK2)
|
|
27.715 (74/267) |
1.54E-20 |
MEK kinase kinase 2 (MAP4K2)
|
|
27.099 (71/262) |
1.95E-20 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
32.661 (81/248) |
2.17E-20 |
Serine/threonine-protein kinase NLK (NLK)
|
|
26.446 (96/363) |
2.63E-20 |
SIK family kinase 3 (SIK3)
|
|
31.679 (83/262) |
3.44E-20 |
Cyclin-dependent kinase 1 (CDK1)
|
|
33.186 (75/226) |
3.52E-20 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
32.367 (67/207) |
3.82E-20 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
25.256 (74/293) |
4.97E-20 |
Salt-inducible kinase 2 (SIK2)
|
|
29.097 (87/299) |
5.19E-20 |
ERK activator kinase 5 (MAP2K5)
|
|
27.055 (79/292) |
5.70E-20 |
Cyclin-dependent kinase 2 (CDK2)
|
|
34.123 (72/211) |
8.80E-20 |
ERK activator kinase 1 (MEK1)
|
|
25.581 (77/301) |
8.80E-20 |
NIMA-related kinase 7 (NEK7)
|
|
24.809 (65/262) |
1.09E-19 |
Salt-inducible kinase 1 (SIK1)
|
|
30.116 (78/259) |
1.15E-19 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
30.116 (78/259) |
1.21E-19 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
28.105 (86/306) |
1.29E-19 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
27.640 (89/322) |
1.31E-19 |
Death-associated protein kinase 3 (DAPK3)
|
|
28.185 (73/259) |
1.37E-19 |
TAO kinase 3 (TAOK3)
|
|
30.147 (82/272) |
1.46E-19 |
Unc-51 like kinase 3 (ULK3)
|
|
30.418 (80/263) |
1.48E-19 |
PDZ binding kinase (PBK)
|
|
29.839 (74/248) |
1.72E-19 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
24.199 (68/281) |
2.40E-19 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
31.496 (80/254) |
5.21E-19 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
26.877 (68/253) |
5.67E-19 |
Myosin-IIIa (MYO3A)
|
|
28.094 (84/299) |
7.03E-19 |
Cyclin-dependent kinase 3 (CDK3)
|
|
34.634 (71/205) |
9.59E-19 |
Doublecortin-like kinase 2 (DCLK2)
|
|
29.064 (59/203) |
1.31E-18 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
26.909 (74/275) |
1.37E-18 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
27.636 (76/275) |
1.37E-18 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
27.402 (77/281) |
1.96E-18 |
Rho-associated protein kinase 2 (ROCK2)
|
|
30.870 (71/230) |
2.37E-18 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
30.000 (66/220) |
2.64E-18 |
MEK kinase kinase 1 (MAP4K1)
|
|
28.519 (77/270) |
2.79E-18 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
27.757 (73/263) |
2.87E-18 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
30.180 (67/222) |
3.51E-18 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
28.958 (75/259) |
4.99E-18 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
30.660 (65/212) |
5.15E-18 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
27.817 (79/284) |
5.21E-18 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
26.616 (70/263) |
5.24E-18 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
28.521 (81/284) |
6.25E-18 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
30.047 (64/213) |
6.63E-18 |
Serine/threonine-protein kinase 33 (STK33)
|
|
28.436 (60/211) |
7.35E-18 |
Protein kinase G2 (PRKG2)
|
|
27.957 (78/279) |
8.01E-18 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
32.512 (66/203) |
8.90E-18 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
26.481 (76/287) |
9.44E-18 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
29.187 (61/209) |
1.00E-17 |
Rhodopsin kinase GRK1 (GRK1)
|
|
32.178 (65/202) |
1.07E-17 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
28.958 (75/259) |
1.21E-17 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
29.384 (62/211) |
1.45E-17 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
29.545 (65/220) |
1.93E-17 |
Cyclin-dependent kinase 6 (CDK6)
|
|
27.402 (77/281) |
2.22E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
28.235 (72/255) |
2.26E-17 |
Rho-associated protein kinase 1 (ROCK1)
|
|
30.488 (75/246) |
2.33E-17 |
TGF-beta receptor type I (TGFBR1)
|
|
30.415 (66/217) |
2.48E-17 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
28.169 (80/284) |
2.48E-17 |
Cyclin-dependent kinase 4 (CDK4)
|
|
29.393 (92/313) |
2.53E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
29.134 (74/254) |
3.24E-17 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
26.894 (71/264) |
3.27E-17 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
30.435 (63/207) |
3.48E-17 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
28.996 (78/269) |
4.10E-17 |
Bone morphogenetic protein receptor (BMPR2)
|
|
27.799 (72/259) |
4.33E-17 |
Myosin light chain kinase 3 (MYLK3)
|
|
30.882 (63/204) |
4.53E-17 |
Omphalocele kinase 1 (NUAK1)
|
|
28.641 (59/206) |
4.83E-17 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
26.977 (58/215) |
5.27E-17 |
Citron Rho-interacting kinase (CIT)
|
|
32.083 (77/240) |
5.73E-17 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
29.048 (61/210) |
5.92E-17 |
Polo-like kinase 4 (PLK4)
|
|
31.132 (66/212) |
5.97E-17 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
27.509 (74/269) |
7.16E-17 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
28.916 (72/249) |
7.35E-17 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
28.253 (76/269) |
7.51E-17 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
31.455 (67/213) |
7.58E-17 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
27.953 (71/254) |
8.38E-17 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
28.623 (79/276) |
8.60E-17 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
26.277 (72/274) |
8.87E-17 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
29.187 (61/209) |
1.28E-16 |
Protein kinase D (PRKD1)
|
|
30.986 (66/213) |
1.54E-16 |
Myosin-IIIb (MYO3B)
|
|
28.464 (76/267) |
2.07E-16 |
BR serine/threonine kinase 2 (BRSK2)
|
|
29.242 (81/277) |
2.30E-16 |
Activin receptor type IB (ACVR1B)
|
|
30.415 (66/217) |
2.41E-16 |
Protein kinase C alpha (PRKCA)
|
|
26.132 (75/287) |
2.64E-16 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
29.557 (60/203) |
2.82E-16 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
27.119 (64/236) |
2.90E-16 |
Death-associated protein kinase 1 (DAPK1)
|
|
27.132 (70/258) |
3.66E-16 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
31.019 (67/216) |
4.00E-16 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
27.344 (70/256) |
4.30E-16 |
Aurora kinase B (AURKB)
|
|
27.376 (72/263) |
4.33E-16 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
30.222 (68/225) |
4.35E-16 |
Death-associated protein kinase 2 (DAPK2)
|
|
29.048 (61/210) |
6.20E-16 |
BR serine/threonine kinase 1 (BRSK1)
|
|
28.016 (72/257) |
7.42E-16 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
25.455 (70/275) |
7.74E-16 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
26.374 (72/273) |
8.67E-16 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
26.596 (75/282) |
9.23E-16 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
27.941 (76/272) |
9.42E-16 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
32.044 (58/181) |
1.08E-15 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
31.455 (67/213) |
1.13E-15 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
30.222 (68/225) |
1.34E-15 |
Serine/threonine-protein kinase 35 (STK35)
|
|
33.562 (49/146) |
1.38E-15 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
29.744 (58/195) |
1.66E-15 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
32.222 (58/180) |
1.66E-15 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
28.636 (63/220) |
1.71E-15 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
26.923 (56/208) |
1.94E-15 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
28.502 (59/207) |
1.97E-15 |
Serine/threonine-protein kinase cot (COT)
|
|
28.077 (73/260) |
2.51E-15 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
27.404 (57/208) |
2.74E-15 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
28.916 (72/249) |
2.95E-15 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
26.971 (65/241) |
4.62E-15 |
Protein kinase C iota (PRKCI)
|
|
26.168 (56/214) |
5.51E-15 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
34.000 (68/200) |
8.46E-15 |
Yet another novel kinase 2 (STK32B)
|
|
26.316 (70/266) |
9.16E-15 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
31.401 (65/207) |
9.96E-15 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
32.353 (66/204) |
1.23E-14 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
25.366 (52/205) |
1.37E-14 |
Protein kinase N1 (PKN1)
|
|
29.218 (71/243) |
1.61E-14 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
24.579 (73/297) |
1.71E-14 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
25.817 (79/306) |
2.00E-14 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
25.888 (51/197) |
2.85E-14 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
29.744 (58/195) |
3.33E-14 |
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
28.638 (61/213) |
3.37E-14 |
Cyclin-dependent kinase 7 (CDK7)
|
|
31.754 (67/211) |
3.40E-14 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
25.763 (76/295) |
3.51E-14 |
Cyclin-dependent kinase 16 (CDK16)
|
|
28.794 (74/257) |
3.75E-14 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
29.044 (79/272) |
4.02E-14 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
31.646 (50/158) |
4.07E-14 |
Protein kinase N2 (PKN2)
|
|
31.102 (79/254) |
4.18E-14 |
Testis-specific serine kinase 2 (TSSK2)
|
|
30.000 (78/260) |
4.26E-14 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
30.116 (78/259) |
4.60E-14 |
Protein kinase C theta (PRKCQ)
|
|
25.600 (64/250) |
5.21E-14 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
27.632 (63/228) |
5.34E-14 |
NF-kappa-B-activating kinase (TBK1)
|
|
25.909 (57/220) |
6.01E-14 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
31.373 (64/204) |
6.14E-14 |
Checkpoint kinase-1 (CHK1)
|
|
29.717 (63/212) |
6.64E-14 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
29.358 (64/218) |
6.80E-14 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
29.344 (76/259) |
6.88E-14 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
34.286 (60/175) |
7.36E-14 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
33.171 (68/205) |
7.54E-14 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
30.928 (60/194) |
7.91E-14 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
30.303 (60/198) |
7.96E-14 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
33.149 (60/181) |
8.29E-14 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
26.357 (68/258) |
1.10E-13 |
Protein kinase C beta (PRKCB)
|
|
26.601 (54/203) |
1.52E-13 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
29.851 (60/201) |
1.60E-13 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
31.863 (65/204) |
1.62E-13 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
27.306 (74/271) |
1.68E-13 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
28.638 (61/213) |
1.69E-13 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
26.786 (60/224) |
2.31E-13 |
Cyclin-dependent kinase 12 (CDK12)
|
|
27.523 (60/218) |
2.33E-13 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
32.195 (66/205) |
2.57E-13 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
26.606 (58/218) |
2.65E-13 |
Misshapen-like kinase 1 (MINK1)
|
|
25.338 (75/296) |
2.66E-13 |
Cyclin-dependent kinase 9 (CDK9)
|
|
28.910 (61/211) |
2.79E-13 |
Cyclin-dependent kinase 13 (CDK13)
|
|
28.182 (62/220) |
2.92E-13 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
27.197 (65/239) |
3.06E-13 |
Polo-like kinase 2 (PLK2)
|
|
20.822 (76/365) |
3.31E-13 |
Activin receptor type IIA (ACVR2A)
|
|
28.618 (87/304) |
3.37E-13 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
29.442 (58/197) |
3.69E-13 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
27.442 (59/215) |
3.76E-13 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
26.496 (62/234) |
3.95E-13 |
Rhodopsin kinase GRK7 (GRK7)
|
|
29.469 (61/207) |
4.85E-13 |
Cyclin-dependent kinase 10 (CDK10)
|
|
32.850 (68/207) |
5.14E-13 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
27.602 (61/221) |
5.32E-13 |
Protein kinase C delta (PRKCD)
|
|
25.287 (66/261) |
5.77E-13 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
31.364 (69/220) |
6.13E-13 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
28.571 (64/224) |
7.36E-13 |
Stress-activated protein kinase 2b (p38 beta)
|
|
28.922 (59/204) |
7.37E-13 |
Obscurin (OBSCN)
|
|
26.275 (67/255) |
8.39E-13 |
Cyclin-dependent kinase 18 (CDK18)
|
|
30.653 (61/199) |
8.41E-13 |
Protein kinase C gamma (PRKCG)
|
|
27.751 (58/209) |
9.32E-13 |
MAP kinase p38 (MAPK12)
|
|
32.843 (67/204) |
1.00E-12 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
29.907 (64/214) |
1.13E-12 |
Protein kinase C epsilon (PRKCE)
|
|
26.891 (64/238) |
1.20E-12 |
Protein kinase C zeta (PRKCZ)
|
|
25.352 (54/213) |
1.63E-12 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
26.047 (56/215) |
1.70E-12 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
28.571 (58/203) |
1.79E-12 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
26.848 (69/257) |
1.80E-12 |
Cyclin-dependent kinase 17 (CDK17)
|
|
29.767 (64/215) |
1.91E-12 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
29.469 (61/207) |
2.26E-12 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
25.000 (69/276) |
2.48E-12 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
26.549 (60/226) |
2.70E-12 |
Serine/threonine-protein kinase MAK (MAK)
|
|
27.208 (77/283) |
2.77E-12 |
Myosin light kinase (MYLK)
|
|
24.031 (62/258) |
2.87E-12 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
26.047 (56/215) |
2.99E-12 |
NDR2 protein kinase (STK38L)
|
|
26.446 (64/242) |
3.22E-12 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
28.910 (61/211) |
3.26E-12 |
MEK kinase kinase 4 (MAP4K4)
|
|
26.277 (72/274) |
4.11E-12 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
25.909 (57/220) |
4.55E-12 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
25.822 (55/213) |
5.06E-12 |
Activin receptor type IIB (ACVR2B)
|
|
26.042 (75/288) |
5.11E-12 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
28.244 (74/262) |
5.28E-12 |
Cyclin-G-associated kinase (GAK)
|
|
27.778 (80/288) |
5.59E-12 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
28.311 (62/219) |
5.78E-12 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
27.982 (61/218) |
8.86E-12 |
Cyclin-dependent kinase 19 (CDK19)
|
|
29.048 (61/210) |
9.63E-12 |
ERK activator kinase 7 (MAP2K7)
|
|
26.437 (69/261) |
9.93E-12 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
24.632 (67/272) |
1.11E-11 |
Protein kinase G1 (PRKG1)
|
|
26.545 (73/275) |
1.22E-11 |
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
28.837 (62/215) |
1.25E-11 |
NDR1 protein kinase (STK38)
|
|
25.403 (63/248) |
1.36E-11 |
Peripheral plasma membrane protein CASK (CASK)
|
|
24.632 (67/272) |
1.71E-11 |
TGF-beta-stimulated factor 1 (STK16)
|
|
23.741 (66/278) |
1.75E-11 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
26.432 (60/227) |
1.79E-11 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
31.220 (64/205) |
1.83E-11 |
Cytoplasmic DRAK1 (STK17A)
|
|
27.586 (56/203) |
1.99E-11 |
Protein kinase C eta type (PRKCH)
|
|
27.273 (57/209) |
3.34E-11 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
31.707 (65/205) |
3.49E-11 |
Adaptor-associated kinase 1 (AAK1)
|
|
23.345 (67/287) |
3.51E-11 |
Nik-related protein kinase (NRK)
|
|
31.217 (59/189) |
3.72E-11 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
30.275 (66/218) |
4.36E-11 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
28.462 (74/260) |
4.72E-11 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
24.302 (87/358) |
5.41E-11 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
24.815 (67/270) |
6.02E-11 |
Triple functional domain protein (TRIO)
|
|
27.381 (69/252) |
6.19E-11 |
Kalirin (KALRN)
|
|
28.302 (60/212) |
6.22E-11 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
26.705 (47/176) |
7.69E-11 |
CDC-like kinase 4 (CLK4)
|
|
29.302 (63/215) |
9.17E-11 |
CaM-kinase IV kinase (CAMKK1)
|
|
29.448 (48/163) |
9.56E-11 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
30.392 (62/204) |
9.62E-11 |
Cyclin-dependent kinase 20 (CDK20)
|
|
29.798 (59/198) |
1.09E-10 |
Cyclin-dependent kinase 14 (CDK14)
|
|
30.808 (61/198) |
1.12E-10 |
Dual specificity protein kinase TTK (MPS1)
|
|
27.222 (49/180) |
1.16E-10 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
31.126 (47/151) |
1.89E-10 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
25.610 (84/328) |
2.15E-10 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
26.904 (53/197) |
2.88E-10 |
BMP-2-inducible protein kinase (BMP2K)
|
|
22.344 (61/273) |
3.56E-10 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
25.081 (77/307) |
4.05E-10 |
Large tumor suppressor homolog 2 (LATS2)
|
|
22.892 (57/249) |
5.19E-10 |
Protein kinase N3 (PKN3)
|
|
31.579 (66/209) |
5.52E-10 |
Cyclin-dependent kinase 5 (CDK5)
|
|
27.143 (57/210) |
5.67E-10 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
29.268 (60/205) |
1.17E-09 |
CDC-like kinase 2 (CLK2)
|
|
24.221 (70/289) |
1.18E-09 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
26.047 (56/215) |
1.27E-09 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
23.891 (70/293) |
1.81E-09 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
23.293 (58/249) |
2.07E-09 |
Polo-like kinase 1 (PLK1)
|
|
25.483 (66/259) |
2.16E-09 |
CDC-like kinase 1 (CLK1)
|
|
27.907 (60/215) |
2.44E-09 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
24.180 (59/244) |
2.67E-09 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
27.700 (59/213) |
3.54E-09 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
21.569 (55/255) |
4.45E-09 |
Cyclin-dependent kinase 8 (CDK8)
|
|
28.837 (62/215) |
5.42E-09 |
Myotonin-protein kinase (DMPK)
|
|
25.926 (56/216) |
5.54E-09 |
Wee1-like protein kinase (WEE1)
|
|
23.297 (65/279) |
6.79E-09 |
MAPK signal-integrating kinase 1 (MKNK1)
|
|
33.333 (32/96) |
3.30E-08 |
Membrane-associated kinase (PKMYT1)
|
|
25.385 (66/260) |
5.44E-08 |
Wee1-like protein kinase 2 (WEE2)
|
|
22.896 (68/297) |
1.04E-07 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
24.843 (79/318) |
1.06E-07 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
26.267 (57/217) |
1.17E-07 |
CDC-like kinase 3 (CLK3)
|
|
26.047 (56/215) |
1.63E-07 |
Cyclin-dependent kinase 15 (CDK15)
|
|
27.228 (55/202) |
2.69E-07 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
25.094 (67/267) |
5.88E-07 |
Titin (TTN)
|
22.010 (46/209) |
1.36E-06 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
23.600 (59/250) |
1.58E-06 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
33.333 (30/90) |
3.36E-06 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
24.364 (67/275) |
3.50E-06 |
Serine/threonine-protein kinase 40 (STK40)
|
|
22.876 (35/153) |
3.97E-06 |
Ribosomal protein S6 kinase-like 1 (RPS6KL1)
|
|
27.211 (40/147) |
4.77E-06 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
25.652 (59/230) |
4.91E-06 |
Casein kinase II alpha prime (CSNK2A2)
|
|
28.758 (44/153) |
5.03E-06 |
Casein kinase I gamma-2 (CSNK1G2)
|
|
23.028 (73/317) |
5.98E-06 |
PIM-3 protein kinase (PIM3)
|
|
26.007 (71/273) |
2.05E-05 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
24.723 (67/271) |
5.11E-05 |
Nuclear receptor-binding protein 2 (NRBP2)
|
|
29.565 (34/115) |
6.76E-05 |
Casein kinase II alpha (CSNK2A1)
|
|
26.144 (40/153) |
1.27E-04 |
Inactive tyrosine-protein kinase PEAK1 (PEAK1)
|
|
29.167 (35/120) |
1.51E-04 |
Casein kinase I epsilon (CSNK1E)
|
|
25.000 (43/172) |
1.97E-04 |
Casein kinase I delta (CSNK1D)
|
|
34.066 (31/91) |
2.12E-04 |
Ribosomal protein S6 kinase delta-1 (RPS6KC1)
|
|
26.882 (25/93) |
2.51E-04 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
25.490 (39/153) |
4.59E-04 |
Casein kinase I gamma-1 (CSNK1G1)
|
|
21.583 (60/278) |
7.75E-04 |
SCY1-like protein 2 (SCYL2)
|
|
20.648 (51/247) |
1.00E-03 |
Casein kinase I gamma-3 (CSNK1G3)
|
|
22.368 (68/304) |
1.00E-03 |
Casein kinase I alpha (CSNK1A1)
|
|
25.000 (49/196) |
2.00E-03 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
27.711 (46/166) |
2.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |